1555 Objectives Angiogenesis has an impact on the kinetics of FDG (J Nucl Med 2008; 49:
1238-1244). Based on PET and gene expression data, regression functions were calculated …

1473 Objectives: Transport and phosphorylation of FDG in the tumor cells determine
primarily the kinetics of the tracer and the accumulation. However, experimental data have …

[en] Objectives: The kinetics of dynamic PET FDG studies in colorectal tumors and bone
tumors was compared with results obtained from tumor samples and gene chip analysis …

[en] Aim: The kinetics of dynamic PET FDG studies in musculoskeletal tumors was compared
with the quantitative measurements of VEGF expression. Methods: Dynamic PET FDG …

447 Objectives The FDG kinetics is modulated by biological factors like angiogenesis. We
investigated the effect of proliferation associated genes on the tracer kinetics in colorectal …

[en] Objectives: The kinetics of dynamic PET FDG studies in sarcomas was compared with
the quantitative measurements of cyclin-A expression. Methods: Dynamic PET FDG studies …

Purpose Treatment of metastatic colorectal cancer frequently includes antiangiogenic
agents such as bevacizumab. Size measurements are inadequate to assess treatment …

1470 Objectives: Present study evaluates a kinetic FDG-PET model as an indicator for
defining tumor aggressiveness and prognosis in patients (pts) with pancreatic cancer …

396 Objectives: Transport and phosphorylation of F-18-Deoxyglucose (FDG) in tumor cells
determine primarily the FDG kinetics. Other biological processes like proliferation may have …

Background To date, there are inconsistent data about relationships between 2-deoxy-2 [18
F] fluoro-D-glucose positron emission tomography (FDG-PET) and expression of vascular …